A small clinical trial published in Nature Communications has demonstrated a novel approach to preventing organ rejection in liver transplant patients. The study involved infusing patients with immune cells from their organ donor prior to transplantation. This technique, known as donor-derived regulatory dendritic cell infusion, aims to ‘educate’ the recipient’s immune system to tolerate the new organ. In the trial, five of six patients who received the cell therapy were able to significantly reduce or completely stop taking traditional immunosuppressive drugs within a year post-transplant, without experiencing rejection. While promising, researchers emphasize these are early results from a very small group of patients, and larger, longer-term studies are needed to confirm safety and efficacy. This approach could potentially reduce the serious side effects associated with lifelong immunosuppression if proven successful. Read the full article: https://www.statnews.com/2026/04/17/organ-transplant-new-approach-immunosuppression-nature-communications-study/?utm_campaign=rss